icon-    folder.gif   Conference Reports for NATAP  
 
  XIX International AIDS Conference
July 22-27, 2012
Washington, DC
Back grey_arrow_rt.gif
 
 
 
Low Rates of Integrase Resistance for Elvitegravir and Raltegravir through Week 96 in the Phase 3 Clinical Study GS-US-183-0145
 
 
  Reported by Jules Levin
IAC July 22-27 2012 Wash DC
 
NA Margot, MS Rhee, J Szwarcberg, and MD Miller Gilead Sciences, Inc., Foster City, CA, USA

IAC1.gif

IAC2.gif

IAC3.gif

IAC4.gif

IAC5.gif

IAC6.gif

IAC7.gif

IAC8.gif

IAC9.gif

IAC10.gif

IAC11.gif